CRISPR/Cas9 Genome-Editing Technology and Potential Clinical Application in Gastric Cancer

被引：6
|
作者：
Almeida, Renata Sanches [1 ]
Wisnieski, Fernanda [1 ,2 ]
Real Karia, Bruno Takao [1 ]
Cardoso Smith, Marilia Arruda [1 ]
机构：
[1] Univ Fed Sao Paulo, Dept Morphol & Genet, Discipline Genet, Rua Botucatu 740, BR-04023900 Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, Dept Med, Discipline Gastroenterol, Rua Loefgreen 1726, BR-04023900 Sao Paulo, Brazil
来源：
GENES | 2022年 / 13卷 / 11期
基金：
巴西圣保罗研究基金会;
关键词：
gastric cancer; CRISPR; gene editing; GENE-EXPRESSION; HUMAN-CELLS; DNA; IDENTIFICATION; CAS; ACTIVATION; RESISTANCE; MIGRATION; INVASION; SEQUENCE;
D O I：
10.3390/genes13112029
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Gastric cancer is the subject of clinical and basic studies due to its high incidence and mortality rates worldwide. Due to the diagnosis occurring in advanced stages and the classic treatment methodologies such as gastrectomy and chemotherapy, they are extremely aggressive and limit the quality of life of these patients. CRISPR/Cas9 is a tool that allows gene editing and has been used to explore the functions of genes related to gastric cancer, in addition to being used in the treatment of this neoplasm, greatly increasing our understanding of cancer genomics. In this mini-review, we seek the current status of the CRISPR/Cas9 gene-editing technology in gastric cancer research and clinical research.
引用
收藏
页数：13
相关论文
共 50 条
  • [31] Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
    Zhang, Song
    Shen, Jiangtao
    Li, Dali
    Cheng, Yiyun
    THERANOSTICS, 2021, 11 (02): : 614 - 648
  • [32] Application of CRISPR/Cas9 genome editing to the study and treatment of disease
    Andrea Pellagatti
    Hamid Dolatshad
    Simona Valletta
    Jacqueline Boultwood
    Archives of Toxicology, 2015, 89 : 1023 - 1034
  • [33] Application of CRISPR/Cas9 genome editing to the study and treatment of disease
    Pellagatti, Andrea
    Dolatshad, Hamid
    Valletta, Simona
    Boultwood, Jacqueline
    ARCHIVES OF TOXICOLOGY, 2015, 89 (07) : 1023 - 1034
  • [34] CRISPR/Cas9 genome editing clinical trials for neurodevelopmental disorders
    Abdelmoula, B.
    Abdelmoula, N. Bouayed
    EUROPEAN PSYCHIATRY, 2024, 67 : S584 - S585
  • [35] HIT-Cas9: A CRISPR/Cas9 Genome-Editing Device under Tight and Effective Drug Control
    Zhao, Chen
    Zhao, Yingze
    Zhang, Jingfang
    Lu, Jia
    Chen, Li
    Zhang, Yue
    Ying, Yue
    Xu, Junjun
    Wei, Shixian
    Wang, Yu
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2018, 13 : 208 - 219
  • [36] Establishment of CRISPR/Cas9 Genome-Editing System Based on Dual sgRNAs in Flammulina filiformis
    Liu, Xiaotian
    Dong, Jianghan
    Liao, Jian
    Tian, Li
    Qiu, Hao
    Wu, Tao
    Ge, Feng
    Zhu, Jing
    Shi, Liang
    Jiang, Ailiang
    Yu, Hanshou
    Zhao, Mingwen
    Ren, Ang
    JOURNAL OF FUNGI, 2022, 8 (07)
  • [37] Agrobacterium rhizogenes-Mediated Genetic Transformation and Establishment of CRISPR/Cas9 Genome-Editing Technology in Limonium bicolor
    Li, Qianqian
    Liu, Shuang
    He, Xuxia
    Li, Haiyun
    Lyu, Shanhua
    Fan, Yinglun
    AGRONOMY-BASEL, 2023, 13 (09):
  • [38] Recent Developments in CRISPR/Cas9 Genome-Editing Technology Related to Plant Disease Resistance and Abiotic Stress Tolerance
    Erdogan, Ibrahim
    Cevher-Keskin, Birsen
    Bilir, Ozlem
    Hong, Yiguo
    Tor, Mahmut
    BIOLOGY-BASEL, 2023, 12 (07):
  • [39] CRISPR/Cas9 genome editing: Fueling the revolution in cancer immunotherapy
    Liu, Xiaojun
    Zhao, Yangbing
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2018, 66 (02) : 39 - 42
  • [40] Break Breast Cancer Addiction by CRISPR/Cas9 Genome Editing
    Yang, Haitao
    Jaeger, MariaLynn
    Walker, Averi
    Wei, Daniel
    Leiker, Katie
    Tao Weitao
    JOURNAL OF CANCER, 2018, 9 (02): : 219 - 231
12345